FdaApplication

NDA 215904

Back to search

Identifiers

Properties

PropertyValue
applicant_nameIMMEDICA PHARMA AB
application_typeNDA
approval_date2022-06-01

Products (1)

ProductActive ingredientStrengthDosage form
ZTALMYGANAXOLONE50MG/MLSUSPENSION;ORAL

1 product